Collagen-DyProQ has immediate applications in studying the synthesis, trafficking, secretion, and degradation of collagen-I caused by mutations in Col1a1 and Col1a2, such as osteogenesis imperfecta, the Ehlers-Danlos syndromes, and Caffey disease. This evidence concerns the gene COL1A2 and Caffey disease.